These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19592629)

  • 1. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.
    Yang X; So WY; Ma RC; Ko GT; Kong AP; Zhao H; Luk AO; Lam CW; Ho CS; Tong PC; Chan JC
    Diabetes Care; 2009 Oct; 32(10):1826-32. PubMed ID: 19592629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry.
    Yang X; So WY; Ma RC; Kong AP; Lee HM; Xu G; Ozaki R; Chan JC
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S185-93. PubMed ID: 22722949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong Diabetes Registry.
    Yang X; Ma RC; So WY; Yu LW; Kong AP; Ko GT; Xu G; Ozaki R; Tong PC; Chan JC
    Cancer; 2011 Feb; 117(4):862-71. PubMed ID: 20939014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes.
    Yang X; Ma RC; So WY; Wang Y; Kong AP; Ozaki R; Xu G; Chan JC
    Diabetes Metab Res Rev; 2014 Jul; 30(5):415-23. PubMed ID: 24677790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.
    Yang X; So W; Ko GT; Ma RC; Kong AP; Chow CC; Tong PC; Chan JC
    CMAJ; 2008 Aug; 179(5):427-37. PubMed ID: 18725615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry.
    Yang X; So WY; Ma RC; Kong AP; Lee HM; Yu LW; Chow CC; Ozaki R; Ko GT; Chan JC
    Diabetes Care; 2011 Feb; 34(2):375-80. PubMed ID: 20980414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of LDL-cholesterol <1.8 mmol/L and statin use with the recurrence of intracerebral hemorrhage.
    Lee TC; Leung WC; Ho C; Chiu MW; Leung IY; Wong YK; Roxanna LK; Sum CH; Lui DT; Cheung RT; Leung GK; Chan KH; Teo KC; Lau KK
    Int J Stroke; 2024 Jul; 19(6):695-704. PubMed ID: 38429252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry.
    Yang X; Ko GT; So WY; Ma RC; Kong AP; Lam CW; Ho CS; Chow CC; Tong PC; Chan JC;
    Diabetes Care; 2008 Dec; 31(12):2294-300. PubMed ID: 18809627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.
    Yang X; Zhao H; Sui Y; Ma RC; So WY; Ko GT; Kong AP; Ozaki R; Yeung CY; Xu G; Tong PC; Chan JC
    Diabetes; 2009 Jul; 58(7):1518-25. PubMed ID: 19401427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients.
    de Vries FM; Voorham J; Hak E; Denig P
    Curr Med Res Opin; 2015 Dec; 31(12):2197-206. PubMed ID: 26359331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statins on all-cause mortality at different low-density-lipoprotein cholesterol levels in Asian patients with type 2 diabetes.
    Chen PH; Wang JS; Lin SY; Li CH; Wang CY; Hu CY; Fu CP; Tsai YT; Lee AT; Chen YW; Li YH; Lee CL
    Curr Med Res Opin; 2018 Nov; 34(11):1885-1892. PubMed ID: 29429368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of albuminuria and renal dysfunction on development of dyslipidaemia in type 2 diabetes--the Hong Kong Diabetes Registry.
    Yang X; So WY; Ma R; Ko G; Kong A; Lam C; Ho CS; Cockram C; Chow CC; Tong P; Chan J
    Nephrol Dial Transplant; 2008 Sep; 23(9):2834-40. PubMed ID: 18372388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
    Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
    J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease.
    Cheng CW; Woo KS; Chan JC; Tomlinson B; You JH
    Br J Clin Pharmacol; 2004 Nov; 58(5):528-35. PubMed ID: 15521901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
    Charlton-Menys V; Betteridge DJ; Colhoun H; Fuller J; France M; Hitman GA; Livingstone SJ; Neil HA; Newman CB; Szarek M; DeMicco DA; Durrington PN
    Clin Chem; 2009 Mar; 55(3):473-80. PubMed ID: 19147732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
    Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.
    Yang X; Lee HM; Chan JC
    Nat Rev Endocrinol; 2015 Jun; 11(6):372-9. PubMed ID: 25801918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of statins on the kidneys in patients with type 2 diabetes.
    Hanai K; Babazono T; Uchigata Y
    Clin Exp Nephrol; 2017 Aug; 21(4):633-642. PubMed ID: 27631405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.